长期抗凝治疗患者的凝血因子分析
Coagulation factor analysis in patients on long-term anticoagulation.
作者信息
Perkins H A, Biben R L
出版信息
Calif Med. 1970 Mar;112(3):1-7.
Abstract
Ninety studies on 58 patients undergoing chronic warfarin therapy included Quick prothrombin times, partial thromboplastin times, thromboplastin generation tests and assays for clotting factors II, V, VII, VIII, IX, X, XI and XII. The results indicate no benefit from supplementation of the Quick tests by any of these other procedures. It is suggested that the Quick test uniformly performed, using a standard uniform thromboplastin, would be the procedure of choice.
摘要
对58例接受慢性华法林治疗的患者进行了90项研究，包括测定凝血酶原时间、部分凝血活酶时间、凝血活酶生成试验以及凝血因子II、V、VII、VIII、IX、X、XI和XII的检测。结果表明，这些其他检测方法对补充凝血酶原时间检测并无益处。建议采用标准统一的凝血活酶，统一进行凝血酶原时间检测，这将是首选的检测方法。
相似文献
1
Coagulation factor analysis in patients on long-term anticoagulation.
Calif Med. 1970 Mar;112(3):1-7.
2
Reappraisal of thromboplastin.
Ann Clin Lab Sci. 1981 May-Jun;11(3):202-10.
3
Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.
J Trauma. 2011 Nov;71(5 Suppl 1):S435-40. doi: 10.1097/TA.0b013e318232e5cb.
4
Effects of preeclampsia on maternal and cord blood clotting activity.
Am J Perinatol. 1985 Oct;2(4):279-82. doi: 10.1055/s-2007-999970.
5
[Evaluation of an automatic clot-sensing instrument : Coag A Pet 200 (author's transl)].
Nouv Rev Fr Hematol (1978). 1978 Jun 10;20(2):199-208.
6
Clotting changes in borderline hypertension.
J Hum Hypertens. 1987 Sep;1(2):101-3.
7
Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
Blood Coagul Fibrinolysis. 2012 Jan;23(1):35-8. doi: 10.1097/MBC.0b013e32834a6136.
8
[Evaluation of the KC10 semi-automatic modular clot detection device].
Nouv Rev Fr Hematol (1978). 1983;25(2):113-21.
9
Coagulation, fibrinolysis, and kinin generation in adult cats.
Am J Vet Res. 1982 Aug;43(8):1478-80.
10
In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.
Thromb Res. 2013 Sep;132(3):381-5. doi: 10.1016/j.thromres.2013.07.020. Epub 2013 Jul 31.
引用本文的文献
1
Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation.
J Blood Med. 2010;1:57-60. doi: 10.2147/JBM.S8938. Epub 2010 May 3.
本文引用的文献
1
A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
Am J Med. 1961 Oct;31:547-54. doi: 10.1016/0002-9343(61)90138-3.
2
Relation between levels of plasma thromboplastin component (PTC) and prothrombin times by the P&P and Quick methods in patients receiving warfarin.
N Engl J Med. 1962 Jul 19;267:125-30. doi: 10.1056/NEJM196207192670303.
3
Bleeding from occult tumors during anticoagulant therapy.
Circulation. 1962 May;25:804-6. doi: 10.1161/01.cir.25.5.804.
4
A simple assay method for factor X (Stuart-Prower factor).
Proc Soc Exp Biol Med. 1962 Mar;109:754-6. doi: 10.3181/00379727-109-27328.
5
Thrombotest. A new method for controlling anticoagulant therapy.
Lancet. 1959 Nov 7;2(7106):754-8. doi: 10.1016/s0140-6736(59)90857-8.
6
THE INTERACTION OF CONTACT PRODUCT AND FACTOR IX.
Thromb Diath Haemorrh. 1964 Apr 15;11:155-66.
7
Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma.
Blood. 1963 Jul;22:35-43.
8
A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom.
J Lab Clin Med. 1960 Apr;55:625-32.
9
A simple, specific one-stage assay for plasma thromboplastin antecedent activity.
J Lab Clin Med. 1961 May;57:771-80.
10
Levels of blood-coagulation factors during anticoagulant therapy with phenindione.
Br Med J. 1961 Apr 29;1(5234):1205-10. doi: 10.1136/bmj.1.5234.1205.
Zotero 插件